Trial Profile
A Study to Evaluate the Mechanism Amplifying Rilpivirine Resistance Conferred by E138K in Patients With HIV-1 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2016
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 05 Jul 2016 New trial record
- 20 Jun 2016 Results published in the Journal of Antimicrobial Chemotherapy